Search filters

List of works by Alexander E Perl

A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia.

scientific article published on 20 October 2009

Availability of FLT3 inhibitors--how do we use them?

scientific article

Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia

scientific article published on 14 May 2019

Gilteritinib for the treatment of relapsed and/or refractory FLT3-mutated acute myeloid leukemia

scientific article published on 27 August 2019

Gilteritinib induces differentiation in relapsed and refractory -mutated acute myeloid leukemia

scientific article published on 01 May 2019

Improving Response to FLT3 Inhibitors-BCL2 the Rescue?

scientific article published on 12 September 2019

Optimizing Chimeric Antigen Receptor T-Cell Therapy for Adults With Acute Lymphoblastic Leukemia

scientific article published on 09 December 2019

Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma.

scientific article published on 6 June 2015

Phase 2b study of 2 dosing regimens of quizartinib monotherapy in -ITD-mutated, relapsed or refractory AML

Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial.

scientific article

Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens

scientific article published on June 5, 2013

Risk of Invasive Fungal Infections in Patients with High-Risk MDS and AML Receiving Hypomethylating Agents

scientific article published on 03 April 2020

Updated safety of midostaurin plus chemotherapy in newly diagnosed FLT3 mutation-positive acute myeloid leukemia: the RADIUS-X expanded access program

scientific article published on 19 August 2020

Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation

scientific article published on 01 June 2020